Combination of Cisplatin Plus Gemcitabine Induction Chemotherapy and Intensity-modulated radiotherapyIntensity-modulated Radiotherapy With or Without Concurrent Cisplatin for NPC
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Janjun Li, M.D.
Sun Yat-Sen University Cancer Center
Principal Investigator - Lizhi Liu, M.D.
Sun Yat-Sen University Cancer Center
Principal Investigator - yong Su, M.D.
Sun Yat-Sen University Cancer Center
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cancer Center,sun Yat-Sen University
Guangzhou, Guangdong, China
Recruiting - State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-Sen University
Guangzhou, China
Jian-jun Li, M.D.Li-zhi Liu, M.D.Not, yet, recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2013
- Primary completion
- 31 Dec 2016
- Completion
- 31 Dec 2016
- Last update posted
- 30 Jul 2013
- Registered enrollment
- 300
- Registry id
- NCT01854203
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.